AU521404B2 - A purified cancer-associated protein - Google Patents

A purified cancer-associated protein

Info

Publication number
AU521404B2
AU521404B2 AU47172/79A AU4717279A AU521404B2 AU 521404 B2 AU521404 B2 AU 521404B2 AU 47172/79 A AU47172/79 A AU 47172/79A AU 4717279 A AU4717279 A AU 4717279A AU 521404 B2 AU521404 B2 AU 521404B2
Authority
AU
Australia
Prior art keywords
associated protein
purified cancer
cancer
purified
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU47172/79A
Other languages
English (en)
Other versions
AU4717279A (en
Inventor
Kurt Frimann Berg
Kurt Baekgaard Osther
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfred Benzon AS
Original Assignee
Alfred Benzon AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfred Benzon AS filed Critical Alfred Benzon AS
Publication of AU4717279A publication Critical patent/AU4717279A/en
Application granted granted Critical
Publication of AU521404B2 publication Critical patent/AU521404B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU47172/79A 1978-05-17 1979-05-17 A purified cancer-associated protein Ceased AU521404B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK216378 1978-05-17
DK216378 1978-05-17

Publications (2)

Publication Number Publication Date
AU4717279A AU4717279A (en) 1979-11-22
AU521404B2 true AU521404B2 (en) 1982-04-01

Family

ID=8110498

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47172/79A Ceased AU521404B2 (en) 1978-05-17 1979-05-17 A purified cancer-associated protein

Country Status (15)

Country Link
JP (1) JPS5516291A (fr)
AU (1) AU521404B2 (fr)
BE (1) BE876301A (fr)
DE (1) DE2919833A1 (fr)
ES (1) ES480624A1 (fr)
FI (1) FI791551A (fr)
FR (1) FR2426055A1 (fr)
GB (1) GB2021593A (fr)
IT (1) IT7968046A0 (fr)
LU (1) LU81273A1 (fr)
NL (1) NL7903854A (fr)
NO (1) NO791643L (fr)
NZ (1) NZ190470A (fr)
PT (1) PT69617A (fr)
SE (1) SE7904276L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO830570L (no) * 1982-02-22 1983-08-23 Carlton Med Prod Antistoffer og antigener for diagnose og behandling av cancer
AU569467B2 (en) * 1982-04-07 1988-02-04 Baylor College Of Medicine Immunoglobulin based cancer treating pharmaceutical compositions

Also Published As

Publication number Publication date
ES480624A1 (es) 1980-08-16
FR2426055A1 (fr) 1979-12-14
AU4717279A (en) 1979-11-22
BE876301A (fr) 1979-11-16
NZ190470A (en) 1982-06-29
LU81273A1 (fr) 1979-09-10
PT69617A (fr) 1979-06-01
NL7903854A (nl) 1979-11-20
JPS5516291A (en) 1980-02-04
GB2021593A (en) 1979-12-05
FI791551A (fi) 1979-11-18
DE2919833A1 (de) 1979-11-29
SE7904276L (sv) 1979-11-18
IT7968046A0 (it) 1979-05-17
NO791643L (no) 1979-11-20

Similar Documents

Publication Publication Date Title
AU535936B2 (en) Purified proteins
AU4569779A (en) 4-aza-17-substituted-5a-androstan-3-ones
AU1328683A (en) O-alkoxycarbonyl benzenesulfonylisocyanates
AU5035479A (en) 2-nitroimidazoles
AU4583279A (en) Cycloalkyltriazoles
AU4876779A (en) Oxybenzylidiene-bornanones
AU4529679A (en) N-heterocyclyl-4-piperidinamines
AU4655479A (en) Ear-plugs
AU4398379A (en) 9-amino-dibenzopyrans
AU5009279A (en) Spiro-oxazolidindiones
AU4666779A (en) Azolopyrimidinones
AU4406379A (en) 1-aryloxy-3-hitratoalkylamino-2-propanols
AU4530579A (en) Plansifters
AU4754479A (en) Carbamimido thiaotes
AU4642179A (en) 4-quinolinylaminobenzoylpiperidines
AU5064479A (en) 3-unsubstituted-3-cephems
AU4506179A (en) Nitrodiarylamines
AU4571479A (en) 2-aminopyrimidones
AU4524379A (en) N-oxacyclic-alkylpiperidyl-diazacompounds
AU4830279A (en) Indolealylamines
AU4946279A (en) Imidazoquinoxalines
AU4814679A (en) Rid-mowse
AU4507279A (en) Phenoxyalkylamines
AU4398479A (en) N-azolylalkyl-halogenoacetanilides
AU5095779A (en) N-quinazolinylpiperidyl-lactams